Jaime is a freelance writer for The American Journal of Managed Care® (AJMC®), where she previously worked as an assistant editor.
She has a BA in print journalism from Penn State University. You can connect with Jaime on LinkedIn.
Levels of Certain Thyroid Hormone May Help With Risk Stratification in MM
May 4th 2022With survival of multiple myeloma ranging from less than 1 month to over 10 years, the researchers highlighted the importance of risk stratification to quickly identify patients who are high risk with poor prognosis and could benefit from different treatment strategies and close surveillance.
Read More
Poorer Outcomes Associated With Recurrent aGVHD Warrant Independent Recognition, Says Study
May 2nd 2022After a median follow-up of 535 days, analysis showed that recurrent acute graft-versus-host disease (RaGVHD) carried several implications for survival, leading the researchers to call for further risk stratification of aGVHD.
Read More
Study Gives Insight Into Fidaxomicin’s Gut-Sparing Activity in Clostridioides difficile
May 2nd 2022Fidaxomicin, now commonly used to treat Clostridioides difficile infection, selectively targets the bacterium while sparing crucial gut commensals that protect against colonization. However, knowledge gaps in the molecular basis of its narrow-spectrum activity remain.
Read More
Study Finds Risk of Overinvestigation in Patients With Lung Cancer Not Fit for Anticancer Treatment
April 30th 2022Among a group of patients with lung cancer who were not suitable for anticancer treatment, the researchers found that 40% underwent additional investigations after their initial CT scan before eventually receiving best supportive care.
Read More
Study: Effective Treatment Significantly Improves HRQoL in Recurrent Clostridioides difficile
April 30th 2022The researchers wrote that their findings showcase the need for close monitoring of patients and for effective treatments for those with recurrent infection, which occurs in 15%-30% of all patients with Clostridioides difficile.
Read More
MoCA Scores in HD Correlate With Caudate Atrophy, Cortical Thinning, Says New Research
April 24th 2022The findings suggest that the tool can be used to not only assess cognitive impairment in Huntington disease (HD) but also to detect brain atrophy patterns associated with cognitive status in these patients.
Read More
New Study Details Frequency of SDOH Documentation Among Patients With Lung Cancer
April 22nd 2022A decade’s worth of data included more than 5 million social determinants of health (SDOH) attributes across nearly 2 million clinical notes from the patient visits extrapolated from a natural language processing system.
Read More
Pretreatment PROs May Have Survival Implications in DLBCL, Finds Exploratory Study
April 12th 2022The researchers found that the prognostic values for both overall and progression-free survival remained even after adjusting for the International Prognostic Index, a widely used prognostic model of outcomes for the disease.
Read More
European Study Shows High Rate of Skin Conditions, Diseases
April 8th 2022When including patients who had a mole check or cancer screening, the proportion of patients with at least 1 dermatological condition or disease increased to 47%; both non-melanoma and melanoma skin cancers were among the top 12 skin diseases reported in the study.
Read More
Nearly One-Fourth of DLBCL Cases May Be Attributable to Obesity in Young Adulthood, Says Study
April 8th 2022Across all measures, researchers found that body mass index in young adults had the strongest association with the risk of non-Hodgkin lymphoma (NHL), estimating that 23.3% of diffuse large B-cell lymphoma (DLBCL) cases and 11% of NHLs overall can be attributed to obesity.
Read More
Researchers Highlight Special Considerations for Managing HS in Certain Populations
April 2nd 2022As potential new treatment options emerge for hidradenitis suppurativa (HS), an inflammatory condition, researchers emphasized the importance of clinicians being prepared to manage patients that have additional health factors.
Read More
High CD47 Expression on HRS Cells Carries Poor Survival Implications in Classical HL
March 27th 2022Retrospective study findings show that CD47 expression on Hodgkin and Reed–Sternberg (HRS) cells varied between patients who had classical Hodgkin lymphoma (HL) and was associated with poor outcomes.
Read More